country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-P12375

Copy Link Print Information

B18 peptide

B18 peptide is a cationic amphipathic α-helical peptidomimetic that binds to the BST-2 extracellular domain and forms a stable complex through intermolecular hydrogen bonds near the N-terminus. B18 peptide competitively inhibits the binding of BST-2 to the extracellular matrix via its extracellular domain, reducing migrasome formation. B18 peptide induces membrane lysis through the formation of pores/water channels and annular pores, impairing membrane integrity. B18 peptide exhibits anticancer activity against breast cancer. B18 peptide can be used for research on breast cancer.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 3027663-77-7
分子式: C₇₈H₁₂₁N₂₃O₂₈S₂
分子量:1893.06

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

B18 peptide 構造式

CAS 番号: 3027663-77-7

価格（税別）

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

Cellular Effect

Cell Line	Type	Value	Description	References
MCF7	IC50	59.8 μM	Cytotoxicity against human MCF7 breast cancer cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay. Cytotoxicity against human MCF7 breast cancer cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.	32155736
SK-BR-3	IC50	11.2 μM	Cytotoxicity against human SKBR3 breast cancer cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay. Cytotoxicity against human SKBR3 breast cancer cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay.	32155736

体外実験

Anti-cancerOthers

Anti-cancer

B18 peptide (0.5-132.0 μM; 24 h) exhibited selective cytotoxic effects, reducing the viability of MCF7 and SKBR3 breast cancer cells, while showing no cytotoxic effects on MDA-MB-231, MDA-MB-468, T47D, and ZR-75-1 cells, and enhanced the viability of PBMCs at high concentrations^[3].

Others

B18 peptide significantly reduces migrasome formation by competitively inhibiting BST2-mediated extracellular matrix adhesion^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay^[3]

Cell Line:

MCF7, SKBR3, MDA-MB-231, MDA-MB-468, T47D, ZR-75-1, and human PBMCs
Concentration:

0, 0.5, 1.0, 2.1, 4.1, 8.3, 16.5, 33.0, 66.0, 132.0 μM
Incubation Time:

24 h
Result:

Reduced cell viability for MCF7 and SKBR3 cell lines with IC₅₀ values of 59.8 μM and 11.2 μM, respectively.
No significant loss of viability was observed for MDA-MB-231, MDA-MB-468, T47D, and ZR-75-1 cell lines, even at the highest concentration tested.
No cytotoxic effect was observed for quiescent human PBMCs; however, at concentrations of 66.0 and 132.0 μM, B18 enhanced cell viability.
Subtle increases in viability were also observed in T47D cells.

Related Protocols :

化学情報

CAS 番号 3027663-77-7
分子量 1893.06
分子式 C₇₈H₁₂₁N₂₃O₂₈S₂
SMILES

O=C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](C)C(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CS)C(N[C@@H](CC(N)=O)C(N[C@@H](CC2=CNC=N2)C(N[C@@H]([C@H](O)C)C(N[C@@H](C(C)C)C(N[C@@H](CCSC)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CN
配列

Gly-Phe-Gln-Asp-Val-Glu-Ala-Gln-Ala-Ala-Thr-Cys-Asn-His-Thr-Val-Met-Ala
シーケンスの短縮

GFQDVEAQAATCNHTVMA
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

取扱説明書 (2659 KB)

参考文献

[1]. Lyu Y, et al. Development of a Cationic Amphiphilic Helical Peptidomimetic (B18L) As A Novel Anti-Cancer Drug Lead. Cancers. 2020 Aug 28;12(9):2448.

[2]. Li X, et al. GPI‑anchored protein nanoclusters license migrasome expansion and serve as exocytic platforms for migrasome. Nat Commun. 2026 Jun 4;17(1):7162. [Content Brief]

[3]. Lyu Y, et al. Development and Characterization of the Shortest Anti-Adhesion Peptide Analogue of B49Mod1. Molecules (Basel, Switzerland). 2020 Mar 06;25(5):1188.

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ